C12N 2710/16033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2710/16033 (Use of viral protein as therapeutic agent other than vaccine) appears on 9 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 20
- Assignees
- 9
- Inventors
- 24
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 3 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Chimeric antigen receptor constructs and their use in CAR-T cells25 Nov 2025US 12,479,890 B2The University of North Carolina at Chapel Hill
- Virus strains28 May 2019US 10,301,600 B2Biovex Limited
- Matrix metalloproteinase cleavable protein polymers for cancer gene therapy9 Apr 2019US 10,253,089 B2University of Utah Research Foundation
- Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof19 Mar 2019US 10,232,003 B2BeneVir Biopharm, Inc.
- Herpes virus strains25 Mar 2014US 8,680,068 B2Biovex Limited
- Cancer-targeted, virus-encoded, regulatable t (catvert) or nk cell (catvern) linkers21 May 2026US 2026/0137779 A1The Research Institute at Nationwide Children' s Hospital
- Compositions and methods for altering amyloid precursor protein (app) processing6 Mar 2025US 2025/0074951 A1Drexel University
- Chimeric antigen receptor constructs and their use in car-t cells3 Aug 2023US 2023/0242589 A1The University of North Carolina at Chapel Hill
- Cancer-targeted, virus-encoded, regulatable t (catvert) or nk cell (catvern) linkers18 Aug 2022US 2022/0257760 A1Research Institute At Nationwide Children's Hospital
- Targeting moiety-decorated oncolytic viruses17 Jun 2021US 2021/0177921 A1Virogin Biotech Canada Ltd
Most cited
By later US patents
- Virus strains63US 7,537,924 B2Biovex Limited · 2009
- Herpes virus strains for gene therapy40US 7,223,593 B2Biovex Limited · 2007
- Virus strains34US 7,063,835 B2Biovex Limited · 2006
- Herpes virus strains for gene therapy19US 8,277,818 B2Biovex Limited · 2012
- Herpes virus strains17US 8,680,068 B2Biovex Limited · 2014